Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1953
https://www.valueinhealthjournal.com/article/S1098-3015(17)32287-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1778
First Page :
A724
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32287-8&doi=10.1016/j.jval.2017.08.1953